Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:52
Arrowhead Pharmaceuticals Total Liabilities (Quarterly) : 1.646B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.646B |
| March 31, 2026 | 1.669B |
| December 31, 2025 | 1.041B |
| September 30, 2025 | 947.02M |
| June 30, 2025 | 860.81M |
| March 31, 2025 | 889.27M |
| December 31, 2024 | 957.62M |
| September 30, 2024 | 948.74M |
| June 30, 2024 | 544.78M |
| March 31, 2024 | 459.74M |
| December 31, 2023 | 452.57M |
| September 30, 2023 | 478.39M |
| June 30, 2023 | 413.87M |
| March 31, 2023 | 426.20M |
| December 31, 2022 | 495.12M |
| September 30, 2022 | 273.60M |
| June 30, 2022 | 277.60M |
| March 31, 2022 | 251.31M |
| December 31, 2021 | 265.98M |
| September 30, 2021 | 301.33M |
| June 30, 2021 | 298.04M |
| March 31, 2021 | 311.25M |
| December 31, 2020 | 44.78M |
| September 30, 2020 | 60.72M |
| June 30, 2020 | 63.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 67.51M |
| December 31, 2019 | 88.07M |
| September 30, 2019 | 105.81M |
| June 30, 2019 | 111.16M |
| March 31, 2019 | 133.30M |
| December 31, 2018 | 169.45M |
| September 30, 2018 | 16.37M |
| June 30, 2018 | 11.14M |
| March 31, 2018 | 13.28M |
| December 31, 2017 | 18.02M |
| September 30, 2017 | 23.16M |
| June 30, 2017 | 25.54M |
| March 31, 2017 | 33.54M |
| December 31, 2016 | 47.05M |
| September 30, 2016 | 33.15M |
| June 30, 2016 | 26.11M |
| March 31, 2016 | 20.68M |
| December 31, 2015 | 19.01M |
| September 30, 2015 | 22.65M |
| June 30, 2015 | 14.45M |
| March 31, 2015 | 18.18M |
| December 31, 2014 | 16.43M |
| September 30, 2014 | 16.83M |
| June 30, 2014 | 10.82M |
| March 31, 2014 | 13.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.661B |
| Intellia Therapeutics, Inc. | 129.46M |
| Denali Therapeutics, Inc. | 322.78M |
| Twist Bioscience Corp. | 226.70M |
| Revolution Medicines, Inc. | 1.717B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.112B |
| Shareholders Equity (Quarterly) | 465.53M |
| Debt to Equity Ratio | 2.956 |
| Current Ratio | 5.899 |
| Net Debt Paydown Yield | -1.11% |